According to the criteria of ASE [19 (link)], the cut-offs for abnormal LV diastolic performance were, as follows: (1) septal mitral annular e′ velocity of < 7 cm/s or lateral mitral annular e′ velocity of < 10 cm/s; (2) average E/e′ ratio of > 14; (3) LAVI of > 34 ml/m2; (4) peak tricuspid regurgitation velocity of > 2.8 m/s. The patients were diagnosed, as follows: LVDD, when > 50% of the indexes met the above criteria; indeterminate LVDD, when merely 50% of the criteria were positive; with risk of developing LVDD but not LVDD yet, when < 50% of the indexes met the above criteria [19 (link)]. For patients with LVDD, the severity of LVDD was defined according to the 2016 EACVI criteria [19 (link), 20 (link)], as follows: mild, when E/A ≤ 0.8 and E ≤ 50 cm/s or ≥ 2 negative criteria (LAVI > 34 ml/m2, average E/e’ > 14, or TR > 2.8 m/s); moderate, when E/A ≤ 0.8 and E > 50 cm/s or 0.8 < E/A < 2 + ≥ 2 positive criteria (LAVI > 34 ml/m2, average E/e’ > 14, or TR > 2.8 m/s); severe, when E/A ≥ 2. Based on the above two criteria, the patients in the present study were categorized into three subgroups: patients with risks for LVDD but without LVDD (n = 237), patients with indeterminate or mild LVDD (n = 113), and patients with moderate or severe LVDD (n = 98). Among these patients, three patients met the criteria for mild LVDD, and seven patients met the criteria for severe LVDD.
Echocardiography Characterization of Left Ventricular Diastolic Dysfunction
According to the criteria of ASE [19 (link)], the cut-offs for abnormal LV diastolic performance were, as follows: (1) septal mitral annular e′ velocity of < 7 cm/s or lateral mitral annular e′ velocity of < 10 cm/s; (2) average E/e′ ratio of > 14; (3) LAVI of > 34 ml/m2; (4) peak tricuspid regurgitation velocity of > 2.8 m/s. The patients were diagnosed, as follows: LVDD, when > 50% of the indexes met the above criteria; indeterminate LVDD, when merely 50% of the criteria were positive; with risk of developing LVDD but not LVDD yet, when < 50% of the indexes met the above criteria [19 (link)]. For patients with LVDD, the severity of LVDD was defined according to the 2016 EACVI criteria [19 (link), 20 (link)], as follows: mild, when E/A ≤ 0.8 and E ≤ 50 cm/s or ≥ 2 negative criteria (LAVI > 34 ml/m2, average E/e’ > 14, or TR > 2.8 m/s); moderate, when E/A ≤ 0.8 and E > 50 cm/s or 0.8 < E/A < 2 + ≥ 2 positive criteria (LAVI > 34 ml/m2, average E/e’ > 14, or TR > 2.8 m/s); severe, when E/A ≥ 2. Based on the above two criteria, the patients in the present study were categorized into three subgroups: patients with risks for LVDD but without LVDD (n = 237), patients with indeterminate or mild LVDD (n = 113), and patients with moderate or severe LVDD (n = 98). Among these patients, three patients met the criteria for mild LVDD, and seven patients met the criteria for severe LVDD.
Corresponding Organization :
Other organizations : Chinese Academy of Medical Sciences & Peking Union Medical College
Variable analysis
- None explicitly mentioned
- Mitral valve peak early (E) and late (A) diastolic velocities
- E/A ratio
- LV isovolumic relaxation time (IVRT)
- LVEF calculated using the biplane Simpson's method
- LV global longitudinal strain (GLS)
- Peak strain dispersion (PSD)
- Presence and severity of LVDD
- Echocardiography conducted by experienced sonographers using the Vivid E95 ultrasound system (GE Vingmed Ultrasound, Horten, Norway)
- Images in cine loop format were analyzed offline using the EchoPAC software (EchoPAC 204, GE Vingmed Ultrasound)
- All indices were measured according to ASE guidelines
- None mentioned
- None mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!